« Previous Release | Next Release »

Media

Corgentech to Present at Needham & Company Fourth Annual Biotechnology Conference

SOUTH SAN FRANCISCO, Calif., May 19, 2005 /PRNewswire-FirstCall via COMTEX/ -- Corgentech Inc. (Nasdaq: CGTK), a biotechnology company, today announced that John P. McLaughlin, the company's president and chief executive officer, will present at the Needham & Company Fourth Annual Biotechnology Conference on May 26, 2005 at 11:30 a.m. EDT in New York City.

To access the live webcast or the subsequent archived recording, log on to www.corgentech.com and go to the Investors page, and click on Webcasts. Please connect to Corgentech's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.

About Corgentech

Corgentech is a biopharmaceutical company focused on the development and commercialization of DNA-based novel therapeutics for significant unmet medical needs. We are creating a pipeline of novel therapeutics focused initially on the treatment of inflammatory diseases, infectious diseases and cancer. For more information on the company and its technologies, please visit www.corgentech.com.

SOURCE Corgentech Inc.

Jennifer Cook Williams, Senior Director, Investor Relations of Corgentech Inc.,
+1-650-624-9600, or [email protected]
http://www.prnewswire.com

Copyright (C) 2005 PR Newswire. All rights reserved.

News Provided by COMTEX

Back to top

MEDIA TOOLS

Print Print page
E-mail E-mail page
PDF Download PDF
Add to Briefcase Add to briefcase

MEDIA CONTACTS

Jennifer Cook Williams
Vice President, Investor Relations
Anesiva, Inc.
Phone: 650-624-9600
Fax: 650-624-7540
[email protected]

Daryl Messinger
WeissComm Partners
Phone: 415-999-2361